No news available.
Board Speciality Departments
- Overview
- Our Team
- Services
- Projects
- Publications
- News
- Events
- Announcements
- Schedule
- Speciality Clinics
- Gallery
Overview
Anatomy
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged. It was popularised in the 1960s with the release of Letraset sheets containing Lorem Ipsum passages, and more recently with desktop publishing software like Aldus PageMaker including versions of Lorem Ipsum.
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged. It was popularised in the 1960s with the release of Letraset sheets containing Lorem Ipsum passages, and more recently with desktop publishing software like Aldus PageMaker including versions of Lorem Ipsum.
Our Team
No Team members listed.
Services
No services listed.
Projects
| S.I. No | Project Title | Project Lead | Project Type | Year of Initiation | Status |
|---|---|---|---|---|---|
| 1 | Example Project | Viraj Shekar | 2024 | ongoing | |
| 2 | Breast Cancer Screening Program | Dr Charles King | Type 2 | 2023 | completed |
| 3 | COVID-19 Response Strategies | Dr Blanca Perez | Type 1 | 2021 | completed |
| 4 | Example Project | Viraj Shekar | 2024 | ongoing | |
| 5 | Librexia AF is a randomized study to evaluate the efficacy and safety of mlivexian versus apixaban in atrial fibrillation. | National Leader: Dr Denis Xavier | Type 1 | 2024 | ongoing |
| 6 | Librexia AF is a randomized study to evaluate the efficacy and safety of mlivexian versus apixaban in atrial fibrillation. | National Leader: Dr Denis Xavier | Type 1 | 2024 | completed |
| 7 | List of International Collaborative Research Projects Approved by HMSC | Dr Manju Rahi | Funding/Collaborating Agency | 2024 | ongoing |
| 8 | Long-term Diabetes Care Study | Dr Mary Hill | Type 2 | 2022 | completed |
| 9 | Medicall collegeeeMedicall collegeee | National Leader: Dr Denis Xavier | Operation | 2025 | ongoing |
| 10 | Metabolic Disorders Clinical Trial | Dr Susan Ray | Type 2 | 2022 | completed |
Publications
No Data available for Journal articles.
Book Chapter
What is Lorem Ipsum? Book book book
What is Lorem Ipsum? Repot 222
What is Lorem Ipsum? News
Events
No events available.
Announcements
No announcements available.
Schedule
Schedule not available.
Speciality Clinics
Speciality clinics information not available.
Gallery
No gallery items available.